Swine Bacterial Diseases: Colibacillosis, UTI, and Antimicrobial Resistance
Introduction
Bacterial infections in swine represent a significant burden on global pork production, with Escherichia coli being the most economically important pathogen across all age groups. This article provides a detailed clinical and biological review of two major disease complexes: colibacillosis (enteric and extraintestinal) and urinary tract infections (UTIs) in sows. The discussion also covers antimicrobial resistance (AMR) patterns, zoonotic considerations, and strategies for prudent antibiotic use. The content is intended for veterinary professionals, diagnostic laboratory personnel, and researchers in computational biology and one health.
The question "do pigs have bacteria" is answered affirmatively: swine harbor a diverse microbiota, and under conditions of host stress or immunosuppression, commensal bacteria such as E. coli can become pathogenic. Understanding the transition from commensal to pathogen is central to disease control.
Swine Colibacillosis
Etiology and Pathogenesis
Colibacillosis in swine is caused by pathogenic strains of Escherichia coli that possess specific virulence factors. The bacteria are Gram-negative rods belonging to the family Enterobacteriaceae. Pathogenic strains are classified by serogroup (O antigen), fimbrial type (F antigens), and production of enterotoxins or cytotoxins.
Neonatal and postweaning colibacillosis are the two main clinical forms. In neonatal piglets, enterotoxigenic E. coli (ETEC) expressing fimbriae such as F4 (K88), F5 (K99), F6 (987P), F41, or F18 adhere to intestinal epithelial cells. These fimbriae mediate attachment to specific receptors on enterocytes. The bacteria then secrete heat-labile (LT) and/or heat-stable (STa, STb) enterotoxins. LT activates adenylate cyclase, increasing cyclic AMP and causing chloride secretion and water loss. STa binds to guanylate cyclase C, elevating cyclic GMP with similar secretory effects. Profuse watery diarrhea results in dehydration, acidosis, and death within hours.
Postweaning colibacillosis (PWC) typically occurs 5 to 10 days after weaning and is associated with ETEC strains expressing F18 or F4 fimbriae, often producing STa, STb, and LT. Weaning stress, dietary changes, and loss of maternal immunity predispose piglets. Edema disease (caused by Shiga toxin-producing E. coli, STEC, also called verotoxigenic E. coli or VTEC) is a separate syndrome characterized by neurological signs and subcutaneous edema, mediated by Stx2e toxin.
Clinical Signs and Lesions
In neonatal colibacillosis, piglets develop yellow, watery diarrhea within the first week of life. Dehydration, sunken eyes, and lethargy are evident. Mortality can reach 50% without intervention. Postweaning colibacillosis presents as pasty to watery diarrhea, often with undigested feed particles. Edema disease manifests as periorbital, eyelid, and laryngeal edema, ataxia, and convulsions. Gross pathology in colibacillosis reveals fluid-filled intestines, hyperemic mesenteric vessels, and sometimes gastric ulceration.
Diagnosis
Diagnosis is based on clinical signs, necropsy, and laboratory confirmation. Fecal samples or intestinal contents are cultured on MacConkey agar. Lactose-fermenting colonies are tested for E. coli by biochemical panels or matrix-assisted laser desorption/ionization time-of-flight (MALDI-TOF) mass spectrometry. Virulence gene detection by multiplex polymerase chain reaction (PCR) targeting fimbrial (F4, F5, F6, F18, F41) and toxin genes (STa, STb, LT, Stx2e) is standard. Serotyping using O and F antisera remains useful in outbreak investigations. Antimicrobial susceptibility testing by disk diffusion or broth microdilution should be performed on isolates.
Urinary Tract Infections in Sows
Etiology and Risk Factors
Urinary tract infections (UTIs) in sows are predominantly caused by uropathogenic E. coli (UPEC). Other bacteria such as Streptococcus suis, Actinobaculum suis (formerly Eubacterium suis), and Klebsiella pneumoniae are also isolated but less frequently. UPEC strains possess adhesins (e.g., type 1 fimbriae, P fimbriae) that bind to uroepithelial receptors. Additional virulence factors include hemolysin, cytotoxic necrotizing factor, and siderophore systems.
Risk factors include confinement in gestation stalls with limited exercise, poor hygiene, vulvar contamination from feces, and structural abnormalities of the urinary tract. Sows are particularly susceptible during the periparturient period due to hormonal changes and reduced water intake.
Clinical Signs and Diagnosis
Affected sows may show dysuria, hematuria, purulent vaginal discharge, and fever. Chronic infections often present subclinically, leading to cystitis, pyelonephritis, and reduced reproductive performance. Diagnosis relies on urinalysis: dipstick testing for leukocyte esterase, nitrite, and blood; microscopic examination for bacteria and white blood cells. Quantitative urine culture with colony counts above 10^5 CFU/mL is confirmatory. Isolation and identification of E. coli with antimicrobial susceptibility testing guide therapy. Imaging such as ultrasonography can detect bladder wall thickening or renal abscesses.
Antimicrobial Resistance in Swine E. coli
Mechanisms and Prevalence
Antimicrobial resistance (AMR) in swine E. coli is a growing concern globally. Resistance can be intrinsic or acquired via mutation or horizontal gene transfer. Plasmids, integrons, and transposons carry resistance genes for multiple drug classes. Common resistance phenotypes include:
- Beta-lactam resistance: Extended-spectrum beta-lactamases (ESBLs) such as CTX-M, TEM, and SHV types; AmpC beta-lactamases.
- Fluoroquinolone resistance: Mutations in gyrase (gyrA, gyrB) and topoisomerase IV (parC, parE) genes, plus plasmid-mediated quinolone resistance (PMQR) determinants (qnr, aac(6')-Ib-cr).
- Tetracycline resistance: Efflux pumps encoded by tet(A), tet(B), and ribosomal protection proteins tet(M), tet(O).
- Aminoglycoside resistance: Aminoglycoside-modifying enzymes (acetyltransferases, phosphotransferases).
- Colistin resistance: Plasmid-mediated mcr-1 to mcr-9 genes, with mcr-1 widely reported in swine isolates.
Surveillance data indicate high resistance rates to tetracyclines, ampicillin, and sulfonamides in many regions. Resistance to fluoroquinolones and third-generation cephalosporins is increasing, limiting therapeutic options. Colistin, a last-resort drug for human infections, is still used in some swine production systems, driving mcr gene dissemination.
Implications for One Health
AMR in swine E. coli poses risks both for veterinary treatment failure and for zoonotic transmission through the food chain. "Pig farmer bacteria" can be carried by healthy pigs and shed into the environment. "Pig meat bacteria" refers to the contamination of pork carcasses during slaughter, which can introduce resistant E. coli into the human food supply. Cross-contamination in abattoirs and retail meat is a documented pathway.
Zoonotic Considerations and Public Health
The question of whether pigs have bacteria that can infect humans is central to one health. Swine are reservoirs for several E. coli pathotypes with zoonotic potential. Shiga toxin-producing E. coli (STEC) strains, including O157:H7 and non-O157 serogroups, can be carried asymptomatically by pigs. Although pigs are less commonly implicated than cattle, outbreaks have been linked to pork products. ESBL-producing E. coli of swine origin have been isolated from farmers and abattoir workers, indicating direct occupational exposure.
The term "pig farmer bacteria" often refers to livestock-associated E. coli clones that share resistance genes with human clinical isolates. Whole genome sequencing (WGS) analyses reveal overlapping sequence types (e.g., ST10, ST131, ST648) in swine and human populations. Prudent antibiotic use in swine operations is essential to reduce the selective pressure that drives resistance.
For further reading on zoonotic transmission of bacterial diseases from livestock, see the article Livestock Zoonoses: A Comprehensive Overview of Bacterial and Viral Diseases Transmitted from Farm Animals to Humans.
Prudent Antibiotic Use and Alternative Strategies
Rational antimicrobial therapy should be guided by culture and susceptibility results. For colibacillosis, oral or parenteral antibiotics such as amoxicillin, trimethoprim-sulfonamide, or ceftiofur may be used, but resistance profiles must be considered. Fluoroquinolones and colistin should be reserved for cases with no alternative. In sows with UTIs, treatment duration of 3 to 5 days is typical; recurrent cases may require longer therapy and correction of predisposing factors.
Non-antimicrobial approaches are critical to reducing reliance on antibiotics. These include:
- Vaccination: Commercial vaccines targeting ETEC fimbriae (F4, F5, F6, F41) for sows (passive immunity via colostrum) and oral vaccines for piglets.
- Probiotics and prebiotics: Lactobacillus spp., Bacillus spp., and mannan-oligosaccharides compete with pathogens and modulate gut microbiota.
- Organic acids: Feed additives such as formic, lactic, or butyric acids lower stomach pH and inhibit bacterial growth.
- Zinc oxide: Pharmacological levels of zinc (2000-3000 ppm) reduce postweaning diarrhea in many countries, though concerns about environmental contamination and AMR co-selection limit long-term use.
- Husbandry improvements: All-in/all-out management, strict hygiene, adequate colostrum intake, and proper ventilation reduce disease pressure.
Diagnostic Workflow
A systematic diagnostic approach for swine colibacillosis and UTIs is presented below. The workflow integrates clinical assessment, laboratory culture, molecular characterization, and antimicrobial susceptibility testing.
flowchart TD
A[Clinical signs: diarrhea, dysuria, fever], > B1[Collect feces/intestinal contents for colibacillosis]
A, > B2[Collect urine via midstream or cystocentesis for UTI]
B1, > C1[Culture on MacConkey agar, 37°C 18-24h]
B2, > C2[Urinalysis: dipstick, microscopy, culture on CLED agar]
C1, > D[Lactose-fermenting colonies; Gram-negative rods]
C2, > D
D, > E[MALDI-TOF or biochemical ID: E. coli]
E, > F1[Multiplex PCR: fimbrial genes + toxin genes for colibacillosis]
E, > F2[Antimicrobial susceptibility testing (disk diffusion or broth microdilution)]
F1, > G1[Pathotype determination: ETEC, STEC, etc.]
F2, > G2[Resistance profile: report MIC and category]
G1, > H[Treatment decision: targeted antimicrobial based on AST]
G2, > H
H, > I[Implement husbandry changes and alternatives]
I, > J[Monitor clinical response; repeat culture if needed]
J, > K[Adjust biosecurity and vaccination protocols]
Conclusion
Swine colibacillosis and UTIs caused by E. coli remain major challenges in intensive pig production. Accurate diagnosis using culture, molecular typing, and susceptibility testing is essential for effective treatment. The rising prevalence of antimicrobial resistance, particularly to critically important drugs, underscores the need for prudent antibiotic use and adoption of alternative control measures. A one health perspective that considers the zoonotic potential of swine E. coli is vital for safeguarding both animal and human health.
References
- Fairbrother JM, Nadeau É. Escherichia coli in swine. In: Zimmerman JJ, Karriker LA, Ramirez A, Schwartz KJ, Stevenson GW, editors. Diseases of Swine. 11th ed. Wiley-Blackwell; 2019.
- World Organisation for Animal Health (WOAH). Manual of Diagnostic Tests and Vaccines for Terrestrial Animals. Chapter 3.9.1: Escherichia coli infections. WOAH; 2023.
- European Medicines Agency. Reflection paper on the use of antimicrobials in food-producing animals. EMA/CVMP/682985/2012.
- Luppi A, D'Incau M. Swine colibacillosis: A review of diagnostic methods and antimicrobial resistance. Vet Microbiol. 2021;253:108965. doi:10.1016/j.vetmic.2020.108965
- Poirel L, Madec JY, Lupo A, et al. Antimicrobial resistance in Escherichia coli. In: Schwarz S, Cavaco LM, Shen J, editors. Antimicrobial Resistance in Bacteria of Animal Origin. ASM Press; 2020.